Spectrum Pharmaceuticals Inc (SPPI)

Add to Watchlists
Create an Alert
7.65 -0.20  -2.55% NASDAQ Jul 22, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/09/2019 16:30 EDT Misc Spectrum Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
08/09/2019 Earnings Spectrum Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
06/19/2019 10:00 PDT Misc Spectrum Pharmaceuticals Inc Annual General Meeting in 2018
05/09/2019 16:30 EDT Misc Spectrum Pharmaceuticals Inc First Quarter Earnings Conference Call in 2019
05/09/2019 Earnings Spectrum Pharmaceuticals Inc First Quarter Earnings in 2019 Release
02/28/2019 16:30 EST Misc Spectrum Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018
02/28/2019 Earnings Spectrum Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release
02/28/2019 Misc Spectrum Pharmaceuticals Inc Annual Report in 2018
11/08/2018 16:30 EST Misc Spectrum Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018
11/08/2018 Earnings Spectrum Pharmaceuticals Inc Third Quarter Earnings in 2018 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.sppirx.com
  • Investor Relations URL: http://investor.sppirx.com/index.cfm
  • HQ State/Province: Nevada
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 09, 2019
  • Last Earnings Release: May. 09, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Dec. 18, 2012
  • Description: Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer. Its other products include FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA.

Top Fund Holders

Symbol Name Weighting
IHE iShares US Pharmaceuticals ETF 0.38%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("SPPI","name")
  • Description: =YCI("SPPI","description")
  • Sector: =YCI("SPPI","sector")
  • Industry: =YCI("SPPI","industry")
  • Est. Current Fiscal Year End: =YCI("SPPI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.